Sign in
Taking peopleNo phase

Smartwatch and AI to help detect obstructive sleep apnea

Tests a smartwatch-based AI model for spotting obstructive sleep apnea in adults.

Key facts

Who runs it
Seoul National University Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Smartwatch-Based AI Model for OSA Prediction (SWOSA)
Status
Recruiting
People taking part
147 people, planned
Started
3 Feb 2025
Expected to end
31 Dec 2026
Type of study
Observational
Treatments tested
  • Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea
Record updated
15 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who came to Seoul National University Hospital with suspected sleep apnea. Signs include snoring, pauses in breathing or strong daytime sleepiness. Participants wear a smartwatch during sleep.

Age
22 to 85 years
Sex
Men and women
Disease stage
Suspected obstructive sleep apnea (breathing stops during sleep), not yet treated
Earlier treatment
People already diagnosed with sleep apnea and now being treated cannot join. This includes PAP therapy, mechanical ventilation, oral appliances or surgery.

Main reasons for not taking part

  • Neuromuscular disease, or long-term use of opioid medicines
  • Severe insomnia not controlled by medicine
  • Extra oxygen therapy for another condition, or baseline oxygen saturation less than 90%
  • Implanted pacemaker, defibrillator or other electronic device
  • Pregnancy, or no experience using smartphones, apps or smartwatches

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Men and women aged 22 to 85 years who visited Seoul National University Hospital with suspected sleep apnea due to symptoms such as snoring, apnea, or excessive daytime sleepiness

Who cannot take part

  • Patients previously diagnosed with sleep apnea who are currently undergoing treatment (e.g., positive airway pressure [PAP] therapy, mechanical ventilation, oral appliances, or surgery)
  • Patients with severe insomnia that is not controlled by medication
  • Patients receiving supplemental oxygen therapy due to underlying conditions such as heart failure, chronic obstructive pulmonary disease, interstitial lung disease, hypoventilation syndrome, or stroke, or whose baseline oxygen saturation is less than 90%
  • Patients with neuromuscular diseases or a history of chronic opioid medication use
  • Patients with implanted cardiac pacemakers, defibrillators, or other electronic devices
  • Patients inexperienced in using smartphones, apps, or smartwatches
  • Pregnant women
  • Patients unable or unwilling to provide written informed consent

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 22 and 85 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to develop an artificial intelligence (AI) model for more accurately diagnosing obstructive sleep apnea (OSA) by collecting blood oxygen saturation and other health information during sleep using a smartwatch.

Read full original descriptionShow less

OSA is common but often underdiagnosed, and the gold-standard diagnostic test, polysomnography, is costly and time-consuming. Smartwatches can provide a variety of health data, such as sleep patterns, blood oxygen saturation, and heart rate, which can help detect key symptoms and signs of OSA.

By developing an AI model that uses smartwatch data to screen for OSA, this study seeks to offer a cost-effective and accessible diagnostic method, ultimately contributing to the early detection and improved treatment rates of OSA.

The group in the trial

  • Smart Watch Group

    Men and women aged 22 to 85 years who visited Seoul National University Hospital with suspected sleep apnea due to symptoms such as snoring, apnea, or excessive daytime.

    Treatment: Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Smartwatch-Based Artificial Intelligence Model for Obstructive Sleep Apnea Prediction
Plain-language title
Smartwatch and AI to help detect obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06792188, who can take part
Record updated
15 May 2025